These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17641357)

  • 1. Does MR imaging improve precision in stroke thrombolysis trials?
    Hackney DB
    Radiology; 2007 Aug; 244(2):323-4. PubMed ID: 17641357
    [No Abstract]   [Full Text] [Related]  

  • 2. Microplasmin and tissue plasminogen activator: comparison of therapeutic effects in rat stroke model at multiparametric MR imaging.
    Chen F; Suzuki Y; Nagai N; Sun X; Wang H; Yu J; Marchal G; Ni Y
    Radiology; 2007 Aug; 244(2):429-38. PubMed ID: 17581889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke lesion volumes and outcome are not different in hemispheric stroke side treated with intravenous thrombolysis based on magnetic resonance imaging criteria.
    Golsari A; Cheng B; Sobesky J; Schellinger PD; Fiehler J; Gerloff C; Thomalla G
    Stroke; 2015 Apr; 46(4):1004-8. PubMed ID: 25700285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue rather than time-based thrombolysis in stroke.
    Yaghi S
    Int J Stroke; 2013 Aug; 8(6):E33. PubMed ID: 23879757
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnetic resonance imaging-guided thrombolysis in minor stroke.
    Desilles JP; Cho TH; Hermier M; Mechtouff-Cimarelli L; Derex L; Nighoghossian N
    Int J Stroke; 2011 Apr; 6(2):178. PubMed ID: 21371285
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomised trials of endovascular treatment of stroke are needed.
    Schott AM
    Lancet Neurol; 2010 Jan; 9(1):30-1. PubMed ID: 20083032
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomised trials of endovascular treatment of stroke are needed.
    Ciccone A; Sterzi R
    Lancet Neurol; 2010 Jan; 9(1):30; author reply 31-2. PubMed ID: 20083033
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain CT signs and the effect of alteplase after stroke.
    Larrue V
    Lancet Neurol; 2015 May; 14(5):458-60. PubMed ID: 25819483
    [No Abstract]   [Full Text] [Related]  

  • 11. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraarterial thrombolysis within the first three hours after acute ischemic stroke in selected patients.
    Moonis M
    Stroke; 2009 Jul; 40(7):2611-2. PubMed ID: 19443796
    [No Abstract]   [Full Text] [Related]  

  • 13. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents.
    Samaniego EA; Linfante I; Dabus G
    Tech Vasc Interv Radiol; 2012 Mar; 15(1):41-6. PubMed ID: 22464301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolysis in stroke--rush is good but do not forget the pharmacology!].
    Andsberg G; Norrving B
    Lakartidningen; 2013 Feb 20-26; 110(8):423. PubMed ID: 23488443
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolysis and hemorrhagic transformation.
    De Keyser J
    Stroke; 2002 Mar; 33(3):724. PubMed ID: 12532967
    [No Abstract]   [Full Text] [Related]  

  • 16. IV and IA thrombolytic stroke strategies are complementary.
    Donnan GA; Davis SM
    Stroke; 2009 Jul; 40(7):2615. PubMed ID: 19443794
    [No Abstract]   [Full Text] [Related]  

  • 17. Stroke: advances in thrombolysis.
    Kaste M
    Lancet Neurol; 2013 Jan; 12(1):2-4. PubMed ID: 23237887
    [No Abstract]   [Full Text] [Related]  

  • 18. Memantine improves safety of thrombolysis for stroke.
    Montagne A; Hébert M; Jullienne A; Lesept F; Le Béhot A; Louessard M; Gauberti M; Orset C; Ali C; Agin V; Maubert E; Vivien D
    Stroke; 2012 Oct; 43(10):2774-81. PubMed ID: 22879098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging-based selection for intra-arterial stroke therapies.
    Morais LT; Leslie-Mazwi TM; Lev MH; Albers GW; Yoo AJ
    J Neurointerv Surg; 2013 May; 5 Suppl 1():i13-20. PubMed ID: 23572461
    [No Abstract]   [Full Text] [Related]  

  • 20. 4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly.
    Schellinger PD; Köhrmann M
    Stroke; 2014 Mar; 45(3):912-3. PubMed ID: 24526060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.